Molecular Mechanisms of Intrinsic Streptomycin Resistance in Mycobacterium abscessus

Streptomycin, the first drug used for the treatment of tuberculosis, shows limited activity against the highly resistant pathogen Mycobacterium abscessus. We recently identified two aminoglycoside-acetylating genes [aac(2′) and eis2] which, however, do not affect susceptibility to streptomycin. This...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Dal Molin, Michael, Gut, Myriam, Rominski, Anna, Haldimann, Klara, Becker, Katja, Sander, Peter
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Mechanisms of Resistance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740355/
https://ncbi.nlm.nih.gov/pubmed/29061744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01427-17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars